The Prevalence of Methamphetamine Dependence among Iranian Women in Methadone Maintenance Therapy in Tehran, Iran

  • Omid Massah Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences
  • Afsaneh Moradi Department of Psychology and Educational Sciences, Al-Zahra University, Tehran, Iran
Keywords: Methamphetamine, Methadone, Prevalence, Treatment, Women


Objective: To date, there has been no specific survey of the prevalence of methamphetamine (MA) dependence among Iranian women in methadone maintenance therapy (MMT). The current study aimed at addressing this critical gap in the literature.Method: This study was part of a larger cross-sectional survey, which was conducted in 36 MMT clinics in Tehran during 2015 and 2016. A researcher-designed questionnaire was devised to collect data on demographics and drug and treatment characteristics. Data were analyzed using SPSS Version 19.Results: Overall, 307 women were in the study sites. Of them, 275 were MA dependent (89.5%) while in MMT. The mean age of the participants, who were MA-dependent, was 38 years. Age of MA dependence was 30 years, and duration of MA dependence was 7years. However, only 24.3% of the participants were currently in MA treatment (i.e. Matrix Model). This was accompanied with high rates of psychiatric hospitalization (29.4%), anxiety (33.4%), and depression (50.9%) because of long years of untreated MA dependence.Conclusion: The study revealed a high prevalence of untreated MA dependence and its adverse health impacts among the participants. However, no considerable treatment for MA dependence had been received by the participants. Psychosocial treatments should address MA dependence in MMT in Iran.


Mehrjerdi ZA, Abarashi Z, Noroozi A, Arshad L, Zarghami M. Correlates of shared methamphetamine injection among methamphetamine-injecting treatment seekers: The first report from iran. Int J STD AIDS 2014; 25: 420-427.

Ghaderi A, Motmaen M, Abdi I, Rasouli-Azad M. Gender differences in substance use patterns and disorders among an iranian patient sample receiving methadone maintenance treatment. Electron Physician 2017; 9: 5354-5362.

Alam Mehrjerdi Z. Crystal in iran: Methamphetamine or heroin kerack. Daru 2013; 21: 22.

Farhadian M, Akbarfahimi M, Hassani Abharian P, Hosseini SG, Shokri S. Assessment of executive functions in methamphetamine-addicted individuals: Emphasis on duration of addiction and abstinence. Basic Clin Neurosci 2017; 8: 147-153.

Bagheri N, Mirzaee M, Jahani Y, Karamouzian M, Sharifi H. Correlates of methamphetamine use among young iranians: Findings of a population-based survey in 2013. Am J Addict 2017; 26: 731-737.

Alam Mehrjerdi Z, Barr AM, Noroozi A. Methamphetamine-associated psychosis: A new health challenge in iran. Daru 2013; 21: 30.

Alaee A, Zarghami M, Farnia S, Khademloo M, Khoddad T. Comparison of brain white matter hyperintensities in methamphetamine and methadone dependent patients and healthy controls. Iran J Radiol 2014; 11: e14275.

Shariatirad S, Maarefvand M, Ekhtiari H. Methamphetamine use and methadone maintenance treatment: An emerging problem in the drug addiction treatment network in iran. Int J Drug Policy 2013; 24: e115-116.

Panenka WJ, Procyshyn RM, Lecomte T, Macewan GW, Flynn SW, Honer WG, et al. Methamphetamine use: A comprehensive review of molecular, preclinical and clinical findings. Drug Alcohol Depend 2013; 129: 167-179.

Rawson RA. Current research on the epidemiology, medical and psychiatric effects, and treatment of methamphetamine use. J Food Drug Anal 2013; 21: S77-s81.

Minozzi S, Saulle R, De Crescenzo F, Amato L. Psychosocial interventions for psychostimulant misuse. Cochrane Database Syst Rev 2016; 9: Cd011866.

American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders, fourth edition, third revision (DSM.IV-TR).USA: Washington; 2000.

Radfar SR, Cousins SJ, Shariatirad S, Noroozi A, Rawson RA. Methamphetamine use among patients undergoing methadone maintenance treatment in iran; a threat for harm reduction and treatment strategies: A qualitative study. International Journal of High Risk Behaviors and Addiction 2016; 5.

Fahimfar N, Sedaghat A, Hatami H, Kamali K, Gooya M. Counseling and harm reduction centers for vulnerable women to hiv/aids in iran. Iran J Public Health 2013; 42: 98-104.

Sami S, Effatpanah M, Moradi A, Massah O. Matrix model as an intensive rehabilitation in three methadone services in iran. Iranian Rehabilitation Journal 2017; 15: 293-297.

Simpson JL, Grant KM, Daly PM, Kelley SG, Carlo G, Bevins RA. Psychological burden and gender differences in methamphetamine-dependent individuals in treatment. J Psychoactive Drugs 2016; 48: 261-269.

Han Y, Lin V, Wu F, Hser YI. Gender comparisons among asian american and pacific islander patients in drug dependency treatment. Subst Use Misuse 2016; 51: 752-762.

Massah O, Effatpanah M, Shishehgar S. Matrix model for methamphetamine dependence among Iranian female methadone patients: the first report from the most populated Persian Gulf country. Iranian Rehabilitation Journal 2017; 15:193-198.

How to Cite
Massah O, Moradi A. The Prevalence of Methamphetamine Dependence among Iranian Women in Methadone Maintenance Therapy in Tehran, Iran. ijps. 13(1):10-4.
Original Article(s)